Vascular Diseases  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00770575 / 2004-004463-30: Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

Completed
2
148
RoW
Pioglitazone and atorvastatin, ACTOS®, AD4833, Atorvastatin
Takeda
Cardiovascular Diseases
10/06
10/06
NCT00771004 / 2006-002237-20: Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

Checkmark P2 data
Mar 2012 - Mar 2012: P2 data
Completed
2
63
Europe
Pioglitazone, ACTOS®, AD4833, Placebo
Takeda
Oxidative Stress, Coronary Artery Disease, Type 2 Diabetes
02/09
02/09
NCT00825266: Insulin Resistance in Pulmonary Arterial Hypertension

Terminated
2
2
US
bosentan, Tracleer, Pioglitazone, Actos
Stanford University
Hypertension, Pulmonary
05/10
05/10
NCT01274403 / 2008-002768-32: A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Completed
2
130
Europe
Melphalan, Prednisone and Thalidomide
Gruppo Italiano Studio Linfomi
Multiple Myeloma
 
 
NCT01186250: Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation

Completed
2
18
US
Pioglitazone, Actos, Placebo
Stanford University
Cardiac Allograft Vasculopathy
08/13
12/13
NCT02195791: Neuroprotection of Pioglitazone in Acute Ischemic Stroke

Terminated
2
4
RoW
Pioglitazone, Placebo
Taipei Medical University Shuang Ho Hospital
Stroke
08/16
08/16

Download Options